Genelux (GNLX) News Today → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free GNLX Stock Alerts $3.86 +0.24 (+6.63%) (As of 04/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGenelux Co. (NASDAQ:GNLX) Major Shareholder Aladar Szalay Sells 48,683 Sharesmarketbeat.com - April 18 at 6:50 PMGenelux (GNLX) Price Target Decreased by 22.96% to 26.52msn.com - April 17 at 8:19 AMVanguard Group Inc. Buys 925,258 Shares of Genelux Co. (NASDAQ:GNLX)marketbeat.com - April 14 at 4:16 AMResearch Analysts Set Expectations for Genelux Co.'s Q1 2024 Earnings (NASDAQ:GNLX)marketbeat.com - April 4 at 8:33 AMGenelux's (GNLX) "Speculative Buy" Rating Reiterated at Benchmarkmarketbeat.com - April 3 at 10:19 AMBrokers Set Expectations for Genelux Co.'s FY2028 Earnings (NASDAQ:GNLX)marketbeat.com - April 3 at 6:46 AMHC Wainwright Lowers Genelux (NASDAQ:GNLX) Price Target to $32.00marketbeat.com - April 2 at 9:12 AMGNLX Stock Earnings: Genelux Misses EPS for Q4 2023investorplace.com - April 2 at 8:06 AMGenelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updateglobenewswire.com - April 1 at 7:00 AMAtossa climbs after cancer therapy updateseekingalpha.com - March 19 at 4:43 PMTD Cowen cuts Immuneering to market perform, cites Phase 1 datamsn.com - March 15 at 2:09 PMShort Interest in Genelux Co. (NASDAQ:GNLX) Expands By 30.3%marketbeat.com - March 15 at 7:23 AMCytomX FY 2023 Earnings Previewmsn.com - March 10 at 7:43 PMShort Interest in Genelux Co. (NASDAQ:GNLX) Rises By 9.9%marketbeat.com - March 5 at 3:17 PMGenelux Stock (NASDAQ:GNLX) Insider Tradesbenzinga.com - February 23 at 8:38 AMG1 Therapeutics stock dives 36% post-market on P3 study updatemsn.com - February 12 at 6:01 PMGenelux Corp. Unveils Future-Oriented Corporate Presentationmsn.com - February 6 at 8:29 AMGenelux Corp. Estimates $23.2 Million in Year-End Assetsmsn.com - February 3 at 10:00 AMHealthcare IT Leaders Adds Health Industry Veteran Mary Mirabelli to Board of Directorsfinance.yahoo.com - January 23 at 1:22 PMShort Interest in Genelux Co. (NASDAQ:GNLX) Rises By 11.1%marketbeat.com - January 2 at 11:09 AMAE Wealth Management LLC Has $4.77 Million Stock Position in Genelux Co. (NASDAQ:GNLX)marketbeat.com - December 24 at 4:36 AMGenelux Stock (NASDAQ:GNLX) Dividends: History, Yield and Datesbenzinga.com - December 21 at 5:17 PMInsider Sell Alert: Director James Tyree Offloads 9,000 Shares of Genelux Corp (GNLX)finance.yahoo.com - December 15 at 3:41 PMGenelux Co. (NASDAQ:GNLX) Director John Thomas Sells 9,000 Sharesmarketbeat.com - December 14 at 9:16 PMHC Wainwright & Co. Initiates Coverage of Genelux (GNLX) with Buy Recommendationmsn.com - November 27 at 10:25 PMGenelux gets fast track status for Olvi-Vec in ovarian cancermsn.com - November 27 at 5:25 PMHC Wainwright starts Genelux at buy, cites Olvi-Vec potentialmsn.com - November 27 at 5:25 PMGenelux Says FDA Grants Fast Track Designation For Olvi-Vec To Treat Ovarian Cancermarkets.businessinsider.com - November 27 at 12:25 PMGenelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancerfinance.yahoo.com - November 27 at 7:24 AMGenelux VP Sold $191K In Company Stockbenzinga.com - November 23 at 12:58 PMGenelux Corporation (NASDAQ:GNLX) most popular amongst retail investors who own 57%, insiders hold 25%finance.yahoo.com - November 17 at 8:49 AMGenelux GAAP EPS of -$0.20 misses by $0.02msn.com - November 15 at 4:05 PMGenelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updatesfinance.yahoo.com - November 14 at 9:22 PMGenelux Corp GNLXmorningstar.com - October 31 at 9:41 PMGenelux 10% owner Aladar Szalay discloses sale of 5,704 sharesmsn.com - October 27 at 7:22 PM10% Owner of Genelux Makes $110K Salebenzinga.com - October 27 at 2:22 PMGenelux Corporation 10% owner discloses sale of 49,987 sharesmsn.com - October 26 at 6:44 PMGenelux Insider Trades Send a Signalbenzinga.com - October 26 at 1:44 PMVP at Genelux Exercises Options Worth $97Kbenzinga.com - October 26 at 1:44 PMGenelux 10% Owner Trades Company's Stockbenzinga.com - October 11 at 3:22 PMGenelux (GNLX) Price Target Increased by 8.99% to 35.02msn.com - October 6 at 7:46 AMGenelux Recent Insider Activitybenzinga.com - October 5 at 8:48 PMAE Wealth Management LLC Invests $434,000 in Genelux Co. (NASDAQ:GNLX)marketbeat.com - October 1 at 4:11 AMGenelux Co. (NASDAQ:GNLX) Major Shareholder Aladar Szalay Sells 11,257 Sharesmarketbeat.com - September 29 at 8:19 PMGenelux VP Acquires 5,200 Shares After Exercising Company Stock Optionsbenzinga.com - September 28 at 1:54 PMGenelux 10% Owner Sold $1.03M In Company Stockbenzinga.com - September 28 at 1:54 PM10% Owner At This Health Care Company Sells $462K of Stockbenzinga.com - September 26 at 4:35 PMDubuque Bank & Trust Co. Buys New Shares in Genelux Co. (NASDAQ:GNLX)marketbeat.com - September 25 at 8:11 AMLifeSteps Financial Inc. Makes New Investment in Genelux Co. (NASDAQ:GNLX)marketbeat.com - September 22 at 10:48 AM10% Owner At This Health Care Company Sells $1.56M of Stockbenzinga.com - September 21 at 1:01 PM Get Genelux News Delivered to You Automatically Sign up to receive the latest news and ratings for GNLX and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! GNLX Media Mentions By Week GNLX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNLX News Sentiment▼0.910.53▲Average Medical News Sentiment GNLX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNLX Articles This Week▼41▲GNLX Articles Average Week Get Genelux News Delivered to You Automatically Sign up to receive the latest news and ratings for GNLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Connect Biopharma News Milestone Pharmaceuticals News Seres Therapeutics News Reviva Pharmaceuticals News Allakos News Oramed Pharmaceuticals News Barinthus Biotherapeutics News DiaMedica Therapeutics News Anixa Biosciences News Cartesian Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNLX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchUrgent alert: open this for a huge profit potentialTimothy SykesThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genelux Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.